Aβ-stimulated microglial inflammatory responses engage mitogen-activated protein kinase (MAPK) and c-Jun amino-terminal kinase (JNK) signaling pathways in AD, which are modulated by URMC-099. Here, WNK2 is linked to Alzheimer disease.